Histopathological Subtypes and Surgical Margins as Risk Factors for Recurrence in Mandibular Ameloblastoma: Systematic Review and Meta-Analysis
Abstract
Background: Ameloblastoma is the most clinically significant benign odontogenic tumor of the mandible. Its tendency to recur after treatment has prompted competing claims about which histological subtypes carry the highest risk and how much bone must be removed around the tumor. We synthesized the evidence on two candidate prognostic factors: histopathological subtype and surgical margin distance.
Methods: We conducted a systematic review following PRISMA 2020. Retrospective cohort and case-control studies of ameloblastoma in which at least 75% of tumors were mandibular were eligible if they reported recurrence counts by histopathological subtype (WHO clinical variant, histological pattern or unicystic subtype) or by surgical margin distance or status. Sources were identified through web-based searching of bibliographic indexes, publisher platforms, open repositories and reference lists of earlier reviews. Risk of bias was assessed with the Quality In Prognosis Studies (QUIPS) tool. Risk ratios (RR) were pooled with DerSimonian–Laird random-effects models, and certainty was graded with the GRADE approach for prognostic factors.
Results: Thirteen studies (14 reports) were included; 11 contributed quantitative data (more than 900 tumors across comparisons). Follicular pattern was associated with a non-significant 53% relative increase in recurrence compared with plexiform pattern (5 studies, 401 tumors; RR 1.53, 95% CI0.88–2.66; I² = 0%), and the estimate fell to RR 1.03 when the largest-weight study was omitted. Conventional (solid/multicystic) ameloblastoma did not recur more often than unicystic ameloblastoma (6 estimable studies, 525 tumors; RR 0.75, 95% CI 0.47–1.18; I² = 7%), a comparison confounded by more conservative treatment of unicystic tumors. Mural unicystic tumors recurred in 3/13 cases versus 0/6 luminal or intraluminal tumors (RR 2.31, 95% CI 0.31–17.34). Margin distance was reported quantitatively in a single cohort of 234 resected tumors: recurrence fell from 22.0% at 1.0 cm to 5.7% at 1.5 cm, 2.7% at 2.0 cm and 0% at 2.5 cm (trend p < 0.001; < 2.0 cm vs ≥ 2.0 cm RR 5.80, 95% CI 1.35–24.94). Overall risk of bias was high in 10 of 13 studies, mainly from confounding by treatment.
Conclusions: Current evidence does not establish follicular, conventional, or mural subtype as independent predictors of recurrence once treatment is considered; certainty is low to very low. A gradient of lower recurrence with wider bony margins up to 2.0 cm is suggested, but it rests on one unreplicated cohort. Prospective, multicentre cohorts with standardized histological classification, measured histological margins and adjustment for treatment are needed.
Registration: The review was not prospectively registered.
Funding: None.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.



